Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial-Reference-Cited by-同舟云学术

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

Published:2020-11-03 Issue:1 Volume:28 Page:82-90
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Takahashi Satoru¹,Kato Kumiko²,Takei Mineo³,Yokoyama Osamu⁴,Gotoh Momokazu⁵

Affiliation:

1. Department of Urology Nihon University School of Medicine TokyoJapan

2. Department of Female Urology Japanese Red Cross Nagoya First Hospital NagoyaJapan

3. Department of Urology Harasanshin Hospital FukuokaJapan

4. Department of Urology University of Fukui FukuiJapan

5. Department of Urology Nagoya University Graduate School of Medicine Nagoya Japan

Funder

Taiho Pharmaceutical

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14411

Reference22 articles.

1. Urinary incontinence as a worldwide problem

2. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction

3. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction

4. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

5. Epidemiologic survey of lower urinary tract symptoms in Japan

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Pharmacotherapy in Older Adults: Urinary Incontinence;Practical Issues in Geriatrics;2023

2. 274 A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF TAS-303 IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE;Continence;2022-06